CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 16 No. 5
Pages: 1  2  
Next
 

CAM Trials Can Be Done in a Traditional Clinical Setting

May 1, 2007

BOSTON—Although some see complementary and alternative medicine (CAM) therapies as lying outside the mainstream clinical setting, Charles Loprinzi MD, of the Mayo Clinic College of Medicine, reviewed 27 CAM trials done in traditional clinical settings, some complete, some in process. These studies are well-designed, adequately powered, are accruing large numbers of patients, and are being published in peer-reviewed medical journals, Dr. Loprinzi said at the Society for Integrative Oncology Third International Conference.

These trials done by the Mayo Clinic, often in conjunction with the North Central Cancer Treatment Group, began in the late 1970s. Their earliest work involved trying to find ways of alleviating some of the adverse symptoms associated with cancer treatments, including mucositis. A randomized trial of 95 patients showed that patients who put ice chips in their mouth for 30 minutes during chemotherapy had significantly less severe ulcerations and a 50% reduction in the number of days of mucositis, compared with a control group. However, a double-blind placebo-controlled trial involving 164 patients found no difference in mucositis between patients who used chamomile or placebo mouthwash.

Another symptom studied by the Mayo group is skin inflammation, such as pain, infection, and scarring, caused by radiotherapy. Aloe vera, an extract from a cactus plant, has been promoted as an agent for treating burns and other skin irritations. A placebo-controlled, double-blind trial of 194 breast cancer patients scheduled to have radiation therapy to the chest, found no difference in the severity of the dermatitis or its duration between the women who received aloe vera gel vs placebo gel.

Dr. Loprinzi reported that randomized trials have failed to show a benefit for vitamin E(Drug information on vitamin e), soy, black cohosh, or acupuncture to prevent hot flashes. The jury is still out on one nutritional supplement DHEA (dehydroepiandrosterone), an androgen that is converted to testosterone in the body. A pilot study with 22 patients found a 64% decrease in hot flashes from baseline. A larger placebo-controlled study is being developed.

Capsaicin for Chronic Pain

Chronic pain can be a problem after mastectomy or limb amputations, he said. Capsaicin cream, a substance made from hot chili peppers, was tested in a placebo-controlled, double-blind study of 99 patients. Patients using the cream had significantly more pain relief throughout the entire 8 weeks of the study. The mean pain reduction was 53% in the capsaicin group vs 17% in the placebo group. Capsaicin cream is known to deplete substance P, a peptide involved in transmitting pain along the nerves.

Extract from the root of the valerian plant is an herbal substance commonly available and used for insomnia, restlessness, and anxiety. Dr. Loprinzi said that researchers are actively recruiting up to 200 cancer patients with insomnia for a randomized placebo-controlled trial to test the effectiveness of valerian.

Several products touted in the lay press have been tested and found wanting, he said. Laetrile from apricot pits was promoted as a promising cancer therapy in the 1970s. A controlled clinical trial with 178 cancer patients not only found no benefit but also found that too much laetrile led to blood cyanide levels near a lethal range. Similarly, there was no significant difference in survival between advanced cancer patients taking 10 g/d of vitamin C vs placebo. Likewise, green tea was found ineffective in a phase II trial of men with metastatic prostate cancer.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy